-
EIB to fund F2G Biotech’s anti-fungal drug research project SHARE
pharmaceutical-technology
November 29, 2018
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and anti-fungal drug development.
-
Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows
pharmafile
October 19, 2018
Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to new research...
-
Gov’t launches £10 antimicrobial research competition
pharmatimes
July 12, 2018
The government has launched a £10 million research competition to encourage the development of novel approaches to combating antimicrobial resistance and improving infection prevention and control.
-
NICE advises restricted use of antibiotics for COPD
pharmatimes
July 11, 2018
The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).
-
UK streams £30m into global fight against AMR
pharmatimes
May 24, 2018
The funding will be delivered through four new projects as part of the Global AMR Innovation Fund (GAMRIF), which will primarily benefit people in low- and middle-income countries, where the burden of infection is greatest.
-
UK and Russian researchers join forces against AMR
europeanpharmaceuticalreview
December 15, 2017
Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have announced a formal agreement to work together.
-
Defining standards & measures for AMR is the need of the hour
biospectrumasia
October 18, 2017
According to one of the report issued by some of the stakeholders last year, antibiotic industry or ingredient manufacturers were responsible for an estimated amount of 30,000-70,000 tons of anti-microbial active waste.